3
24
Helvetica Chimica Acta – Vol. 96 (2013)
Experimental Part
General. Column chromatography (CC): silica gel (SiO ; 230 – 400 mesh; Merck, Germany),
2
Lichroprep RP18 gel (40 – 60 mm, Merck, DE-Darmstadt), and Sephadex LH-20 (Amersham Pharmacia
Biotech, UK). TLC: SiO 60 F and RP-18 F254s SiO plates (Merck, Germany); detection under UV
2
254
2
light and by spraying with 10% aq. H SO soln., followed by heating at 1208 for 1 min. HPLC: Prep.
2
4
HPLC Gilson 306 pump, Gilson-101 RI detector, Phenomenex-Luna-C -(2) column (250 mm ꢁ
1
8
1
0.00 mm i.d., 5 mm); tR in min. UV Spectra: Jasco P-1020 polarimeter in CHCl ; l
(log e) in nm.
max
3
ꢀ1
1
13
IR Spectra: Bruker IFS-66/S FT-IR spectrometer; KBr pellets; in cm . H- and C-NMR spectra: Varian
UNITY INOVA 500 FT-NMR instrument; d in ppm rel. to Me Si as internal standard, J in Hz. ESI- and
4
HR-ESI-MS: VG BIOTECH platform LC/MS spectrometer; in m/z.
Plant Material. The aerial parts of R. laciniata (7.0 kg) were collected at the Taebaek Mountain in
Gangwon-Do Province, Korea, in May 2009, and the plant was identified by one of the authors
(
K. R. L.). A voucher specimen of the plant (SKK-09-06) was deposited with the School of Pharmacy in
Sungkyunkwan University.
Extraction and Isolation. Half-dried aerial parts of R. laciniata (Asteraceae) (7.0 kg) were extracted
with 80% MeOH three times at r.t. (6 ꢁ 12 l, overnignt). The resulting MeOH extracts (400 g) were
suspended in dist. H O (800 ml ꢁ 4), and then successively partitioned with hexane, CHCl , AcOEt, and
2
3
BuOH, yielding residues of 37, 1, 5, and 30 g, resp. The hexane-soluble extract (37 g) was subjected to CC
(
RP-18 (400 g), 90% MeOH): Frs. 1 – 7. Fr. 2 (2 g) was subjected again to CC (SiO (20 g); hexane/
2
CHCl /MeOH 2.5 :3 :0.1): Frs. 2.1 – 2.7. Fr. 2.4 was purified by prep. HPLC (RP-C ; MeOH/H O 85 :15;
3
18
2
2
ml/min): 1 (tR 20 min; 5 mg). Fr. 2.5 (1 g) was subjected to CC (Sephadex LH-20 (100 g); 100%
MeOH): Frs 2.5.1 – 2.5.2. Fr. 2.5.2 (40 mg) was purified by prep. HPLC (RP-C ; MeOH/H O 85 :15;
18
2
2
ml/min): 2 (tR 19 min; 5 mg) and 3 (tR 18 min; 5 mg). Fr. 2.9 was purified by prep. HPLC (RP-C18,
MeOH/H O 60 :40; 2 ml/min): (þ)-syringaresinol (t 15 min; 5 mg).
2
R
(
þ)-4,4’-O-Diangeloylpinoresinol (¼(1S,3aR,4S,6aR)-Tetrahydro-1H,3H-furo[3,4-c]furan-1,4-diyl-
25
bis-[2-methoxybenzene-4,1-diyl] Bis[(2Z)-2-methylbut-2-enoate); 1). Colorless gum. [a]
.17, CHCl ). UV (MeOH): 216 (4.0), 276 (3.9). IR (KBr): 3358, 2942, 2833, 1650, 1453, 1122, 1033.
D
¼ þ14.0 (c ¼
0
3
1
13
þ
þ
8
H- and C-NMR: Table. HR-ESI-MS: 545.2163 ([M þ Na] , C H NaO ; calc. 545.2151).
30
34
(
þ)-4,4’-O-Diangeloylmedioresinol (¼2,6-Dimethoxy-4-[(1S,3aR,4S,6aR)-4-(3-methoxy-4-{[(2Z)-
2
-methylbut-2-enoyl]oxy}phenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]phenyl (2Z)-2-Methylbut-2-
enoate; 2). Colorless gum. [a]
2
5
D
¼ þ52 (c ¼ 0.15, CHCl ). UV (MeOH): 223 (4.0), 275 (4.1). IR
3
1
13
(
KBr): 3357, 2945, 2832, 1660, 1451, 1118, 1031. H- and C-NMR: Table. HR-ESI-MS: 575.2259 ([M þ
þ þ
Na] , C H NaO ; calc. 575.2257).
31
36
9
(
þ)-4,4’-O-Diangeloylsyringaresinol (¼(1S,3aR,4S,6aR)-Tetrahydro-1H,3H-furo[3,4-c]furan-1,4-
25
diylbis-[2,6-dimethoxybenzene-4,1-diyl] Bis[(2Z)-(2-Methylbut-2-enoate]; 3). Colorless gum. [a]
¼
D
þ71.0 (c ¼ 0.15, MeOH). UV (MeOH): 216 (4.0), 272 (3.9). IR (KBr): 3357, 2945, 2832, 1660,
1
13
þ
þ
10
1
6
451, 1116, 10311. H- and C-NMR: Table. HR-ESI-MS: 605.2377 ([M þ Na] , C H NaO ; calc.
32
38
05.2363).
Alkaline Hydrolysis of 1 – 3. Compound 1 (1.7 mg) was hydrolyzed with 0.1m KOH (1 ml) at r.t. for
3
h. After adding H O (3 ml), the mixture was extracted with CHCl three times, and the CHCl extract
2
3
3
was evaporated in vacuo. The CHCl extract was purified through a SiO Waters Sep-pak Vac 12cc
3
2
cartridge (Milford, MA, USA; with CHCl /MeOH 20 :1) to give (þ)-pinoresinol, which was identified by
3
1
H-NMR, MS, and optical-rotation data. Compounds 2 (1.0 mg) and 3 (1.0 mg) were treated by the same
method. The CHCl extract was purified through a SiO Waters Sep-pak Vac 12cc cartridge to give (þ)-
3
2
1
medioresinol, and (þ)-syringaresinol, which were identified by H-NMR, MS, and optical-rotation data.
2
5
1
(
þ)-Pinoresinol. [a] ¼ þ5.0 (c ¼ 0.03, CHCl ). H-NMR (CDCl , 500 MHz): 6.89 (d, J ¼ 2.0,
D
3
3
HꢀC(2,2’)); 6.88 (d, J ¼ 8.0, HꢀC(5,5’)); 6.82 (dd, J ¼ 8.0, 2.0, HꢀC(6,6’)); 4.74 (d, J ¼ 4.0, HꢀC(7,7’));
4
(
.24 (dd, J ¼ 9.0, 7.0, HꢀC(9a,9a’)); 3.91 (s, MeOꢀC(3,3’)); 3.88 (dd, J ¼ 9.0, 3.5, HꢀC(9b,9b’)); 3.09 – 3.11
ꢀ
m, HꢀC(8,8’)). ESI-MS: 357 ([M ꢀ H] ).
2
5
1
(
þ)-Medioresinol. [a]
D
¼ þ20.0 (c ¼ 0.01, CHCl ). H-NMR (CDCl , 500 MHz): 6.87 (d, J ¼ 2.0,
3
3
HꢀC(2)); 6.86 (d, J ¼ 8.0, HꢀC(5)); 6.83 (dd, J ¼ 8.0, 2.0, HꢀC(6)); 6.54 (s, HꢀC(2’,6’)); 4.74 (d, J ¼ 4.0,
HꢀC(7)); 4.70 (d, J ¼ 4.0, HꢀC(7’)); 4.24 (dd, J ¼ 9.0, 7.0, HꢀC(9a,9a’)); 3.91 (s, MeOꢀC(3)); 3.88 (s,